HomepageEarnings Events Newsdesk 13 minutes ago Insulet Corporation (PODD) Q1 2026 Earnings Call Insulet Corporation (NASDAQ: PODD) Q1 2026 Earnings Conference Alkermes plc (ALKS) Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 » « Insulet Corporation (PODD) Q1 2026 Earnings Announcement Newsdesk:
